M. S. Kabir et al. / Tetrahedron Letters 48 (2007) 7269–7273
7273
H. J. Org. Chem. 2004, 69, 2362; (c) Chaumeil, H.;
Signorella, S.; Le Drian, C. Tetrahedron 2000, 56, 9655; (d)
Watanabe, T.; Miyaura, N.; Suzuki, A. Synlett 1992,
207.
Acknowledgments
We thank Matthew E. Dudley for technical help and
The Research Growth Initiative of the University of
Wisconsin-Milwaukee and the UW-System Applied Re-
search Grants Program for support of this work.
7. (a) Sander, H. L. T.; Deelman, B. J.; Koten, G. V. J.
Organomet. Chem. 2004, 689, 2145; (b) Kimbrough, R. D.
Environ. Health Perspect. 1976, 14, 51.
8. Takai, K.; Nitta, K.; Utimoto, K. J. Am. Chem. Soc. 1986,
108, 7408.
References and notes
9. Bosanac, T.; Wilcox, C. S. Tetrahedron Lett. 2001, 42,
4309.
10. Cook, J. M.; Defoe, L.; Kabir, M. S.; Monte, A.; Rott,
M.; Schwan, W. R. US CIP Anti-Infective Agents and
Methods of Use, Application 04/06/2007.
11. Heynekamp, J. J.; Weber, W. M.; Hunsaker, L. A.;
Gonzales, A. M.; Orlando, R. A.; Deck, L. M.; Vander
Jagt, D. L. J. Med. Chem. 2006, 49, 7182.
12. (a) Botella, L.; Carmen, N. Tetrahedron 2004, 60, 5563; (b)
Velder, J.; Ritter, S.; Lex, J.; Schmalz, H.-G. Synthesis
2006, 273.
1. (a) Kataoka, N.; Shelby, Q.; Stambuli, J. P.; Hartwig, J. F.
J. Org. Chem. 2002, 67, 5553; (b) Handbook of Organo-
palladium Chemistry for Organic Synthesis; Negishi, E.,
Ed.; John Wiley & Sons: New York, 2002; (c) Organo-
metallics in Organic Synthesis; Negishi, E., Ed.; John
Wiley & Sons: New York, 1980; (d) Metal-Catalyzed
Cross-Coupling Reactions; Diederich, F., Stang, P. J., Eds.;
Wiley-VCH: New York, 1998.
2. (a) Hasan, J.; Sevignon, M.; Gozzi, C.; Schulz, E.;
Lemarie, M. Chem. Rev. 2002, 102, 1359; (b) Littkle, A.
F.; Fu, G. C. Angew. Chem., Int. Ed. 2002, 41, 4176; (c)
Lessene, G. Aust. J. Chem. 2004, 57.
13. Zhou, J.; Fu, G. C. J. Am. Chem. Soc. 2003, 125,
12527.
14. Typical procedure: Pd-catalyzed Negishi cross-couplings of
aryl halides and arylvinyl iodides. An oven dried round
bottomed flask containing a magnetic stir bar was sealed
with a rubber septum and then evacuated and backfilled
with argon (the sequence was repeated three times) while
cooling. The round bottomed flask was then charged with
arylbromide (1.5 equiv) and dry THF (2 mL). The solu-
tion which resulted was cooled to À78 ꢁC and then n-BuLi
(2.5 M in hexanes 3.0 equiv) was added via a syringe
through the septum, and the solution which resulted was
stirred at À78 ꢁC for 1 h. The dry ZnCl2 (3.0 equiv) was
then added in one solid portion by removal of the septum
at À78 ꢁC. The mixture which resulted was stirred for 1 h
at À78 ꢁC and the flask was removed from the cooling
bath and stirred at room temperature for 1 h. The
Pd2(dba)3 (2 mol %) catalyst was added to the reaction
mixture in one solid portion by removal of the septum and
this was followed by rapid addition of the arylvinyl iodide
in THF via a syringe through the resealed septum. A
previously flame dried reflux condenser was used to cap
the reaction flask and the top of the condenser was sealed
with a septum and teflon. The reaction was kept under an
argon atmosphere. The reaction mixture was immediately
placed in a preheated oil bath at 70 ꢁC and stirred
(magnetic stir) for 3–5 h or stirred at room temperature
for 2–3 h depending on the substrates until the arylvinyl
iodide had been completely consumed as indicated by
examination of a sample of the crude reaction mixture by
1H NMR spectroscopy. The reaction mixture was then
cooled to rt, diluted with water (4 mL), and extracted with
diethylether (4 · 10 mL). The combined organic phases
were dried over Na2SO4 and concentrated under reduced
pressure. The crude material was purified by flash chro-
matography on silica gel to give the pure cross-coupled
product (see Table 3 for yields).
3. (a) Monte, A.; Rott, M.; Defoe, L.; Schwan, W. R. U.S.
Patent Appl. Publ. 2006, 26; (b) Sanghee, K.; Hyojin, K.;
Jae, E. P.; Sungkyu, J.; Sang, K. L.; Young-Jin, C. J. Med.
Chem. 2002, 45, 160; (c) Aggarwal, B. B.; Bhardwaj, A.;
Aggarwal, R. S.; Seeram, N. P.; Shishodia, S.; Takada, Y.
Anticancer Res. 2004, 24, 2783; (d) Wolter, F.; Stein, J.
Drugs Future 2002, 27, 949; (e) Fremont, L. Life Sci. 2000,
66, 663; (f) Jang, M.; Cai, E. N.; Udeani, G. O.; Slowing,
K. V.; Thomas, C. F.; Beecher, C. W. W.; Fong, H. S.;
Farnsworth, N. R.; Kinghorn, A. D.; Metha, R. G.;
Moon, R. C.; Pezzuto, J. M. Science 1997, 275, 218; (g)
The Biochemistry of the Stilbenoids; Gorham, J., Ed.;
Chapman & Hall: London, 1995; (h) Bradamante, S.;
Barenghi, L.; Villa, A. Cardiovasc. Drug Rev. 2004, 22,
169; (i) Belovsky, G.; Percivill, D.; Lewis, K.; Tegos, G. P.;
Ekart, J. J. Nat. Prod. 2004, 67, 481.
4. (a) Ferre-Filmon, K.; Delaude, L.; Demonceau, A.; Noels,
A. F. Coord. Chem. Rev. 2004, 248, 2323; (b) Reetz, M. T.;
Lohmer, G.; Lohmer, R.; Westermann, E. Ger. Offen.
2000, DE 19843012; (c) Alonso, E.; Ramon, D. J.; Yus, M.
J. Org. Chem. 1997, 62, 417; (d) Molander, G. A.;
Bernardi, C. R. J. Org. Chem. 2002, 67, 8424.
5. (a) Tietze, L. F.; Nordmann, G. Synlett 2001, 337; (b)
Maddux, T.; Li, W.; Yu, L. J. Am. Chem. Soc. 1997, 119,
844; (c) Sengupta, S.; Sadhukhan, S. K.; Singh, R. S.; Pal,
N. Tetrahedron Lett. 2002, 43, 1117; (d) Belfield, K. D.;
Chinna, C.; Schaffer Tetrahedron Lett. 1997, 6131; (e)
Guiso, M.; Marra, C.; Farina, A. Tetrahedron Lett. 2002,
43, 597; (f) Thomas, N. F.; Lee, K. C.; Paraidathathu, T.;
Weber, J. F. F.; Awang, K.; Rondeau, D.; Richomme, P.
Tetrahedron 2002, 58, 7201; (g) Beller, M.; Zapf, A. Synlett
1998, 792; (h) Reetz, M. T.; Lohmer, G.; Schwickardi, R.
Angew. Chem., Int. Ed. 1998, 37, 481.
6. (a) Jacqueline, E. M.; Buchwald, S. L. J. Am. Chem. Soc.
2004, 126, 13028; (b) Handy, S. T.; Zhang, Y.; Bergman,